Bioavailability of temazepam in soft gelatin capsules

British Journal of Clinical Pharmacology
L M Fuccella


1 Healthy volunteers received single doses of temazepam 30 mg in conventional gelatin capsules, suppositories or in solution. They experienced marked sedation and sleepiness. The onset of sleepiness was prompt after the administration of the solution; this latter showed the fastest absorption and gave the highest peak plasma levels. This observation led to the development of the soft gelatin capsule. 2 To assess bioavailability of the formulation, plasma levels of temazepam were determined in healthy volunteers after single oral administration of soft and hard capsules, and after seven consecutive night-time doses of the soft capsule. Absorption from the soft gelatin capsule was faster and produced earlier and higher peak plasma levels. There were no differences in relative availability. 3 The apparent half-life of temazepam after night-time administration was shorter than after morning administration, but no change was observed between the first and seventh night-time doses.


Dec 16, 1977·European Journal of Clinical Pharmacology·L M FuccellaG Tognoni


Jan 1, 1983·Psychopharmacology·M D BearyA V Bhat
Jan 1, 1986·European Journal of Clinical Pharmacology·H GhabrialM L Mashford
Nov 21, 1989·European Journal of Pharmacology·D J DijkR H van den Hoofdakker
Jun 1, 1996·Pharmacy World & Science : PWS·L M Hanff, W J Rutten
Oct 1, 1981·Journal of Pharmaceutical Sciences·M DivollR I Shader
Jan 1, 1981·Anaesthesia·A P BeecheyC Studd
Jan 1, 1986·Acta Psychiatrica Scandinavica. Supplementum·J Kanto
Jan 1, 1986·Acta Psychiatrica Scandinavica. Supplementum·P J Cook
Jan 1, 1986·Acta Psychiatrica Scandinavica. Supplementum·M S PathyM J Stoker
Jan 1, 1986·Acta Psychiatrica Scandinavica. Supplementum·B SaletuW Sieghart
Jan 1, 1981·The Journal of International Medical Research·G Frithz, W Groppi
Jul 1, 1981·Pharmacotherapy·M M Mitler
Jul 1, 1984·British Journal of Clinical Pharmacology·D M PierceA N Nicholson

Related Concepts

Biological Availability
Microcapsules Drug Delivery System
Pfizer Brand 1 of Temazepam
Anti-Anxiety Effect

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.